Search

Your search keyword '"ten Kate, F.J.W."' showing total 138 results
Start Over Author "ten Kate, F.J.W."
138 results on '"ten Kate, F.J.W."'

5. In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiology

Author

van Seters, M., ten Kate, F.J.W., van Beurden, M., Verheijen, R.H.M., Meijer, C.J.L.M., Burger, M.P.M., and Helmerhorst, T.J.M.

Subjects
Vulvar diseases -- Development and progression, Vulvar diseases -- Causes of, Vulvar diseases -- Research, Skin diseases -- Diagnosis, Skin diseases -- Research, Health
Published
2007

9. Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett’s esophagus biopsies – towards digital review of Barrett’s esophagus

Author

van der Wel, M.J. (M. J.), Klaver, E. (E.), Duits, L.C. (L. C.), Pouw, R.E. (R. E.), Seldenrijk, K.A. (Kees), Offerhaus, G.J.A. (Johan), Visser, M. (Marjan), ten Kate, F.J.W. (F. J.W.), Biermann, K. (Katharina), Brosens, L.A. (Lodewijk), Doukas, M. (M.), Huysentruyt, C.J. (Clément J.), Karrenbeld, A. (A.), Kats-Ugurlu, G. (Gursah), van der Laan, J.S. (J. S.), Lijnschoten, G. van, Moll, F.C.P., Ooms, A.H.A.G. (Ariadne), Tijssen, J.G.P. (Jan), Bergman, J.J.G.H.M. (Jacques), Meijer, S.L. (Sybren), van der Wel, M.J. (M. J.), Klaver, E. (E.), Duits, L.C. (L. C.), Pouw, R.E. (R. E.), Seldenrijk, K.A. (Kees), Offerhaus, G.J.A. (Johan), Visser, M. (Marjan), ten Kate, F.J.W. (F. J.W.), Biermann, K. (Katharina), Brosens, L.A. (Lodewijk), Doukas, M. (M.), Huysentruyt, C.J. (Clément J.), Karrenbeld, A. (A.), Kats-Ugurlu, G. (Gursah), van der Laan, J.S. (J. S.), Lijnschoten, G. van, Moll, F.C.P., Ooms, A.H.A.G. (Ariadne), Tijssen, J.G.P. (Jan), Bergman, J.J.G.H.M. (Jacques), and Meijer, S.L. (Sybren)

Abstract

Background: Dysplasia assessment of Barrett’s esophagus biopsies is associated with low observer agreement; guidelines advise expert review. We have developed a web-based review panel for dysplastic Barrett’s esophagus biopsies. Objective: The purpose of this study was to test if 10 gastrointestinal pathologists working at Dutch Barrett’s esophagus expert centres met pre-set benchmark scores for quality criteria. Methods: Ten gastrointestinal pathologists twice assessed 60 digitalized Barrett’s esophagus cases, enriched for dysplasia; then r

Published
2019
Full Text
View/download PDF

12. A 'crackleware' oesophagus

Author

Westerterp, M., Busch, O.R.C., Bergman, J.J.G.H.M., ten Kate, F.J.W., and van Lanschot, J.J.B.

Subjects
Esophageal diseases -- Case studies, Esophageal diseases -- Diagnosis, Keratin -- Analysis, Health
Published
2005

13. Effect of neoadjuvant chemoradiotherapy on health-Related quality of life in esophageal or junctional cancer: Results from the randomized CROSS trial

Author

Noordman, B.J. (Bo Jan), Verdam, M.G.E. (Mathilde G.E.), Lagarde, S.M. (Sjoerd), Hulshof, M.C.C.M. (Maarten), Van Hagen, P. (Pieter), van Berge Henegouwen, M.I., Wijnhoven, B.P.L. (Bas), Laarhoven, H.W.M. (Hanneke) van, Nieuwenhuijzen, G.A.P. (Gerard), Hospers, G.A.P. (Geke), Bonenkamp, J.J. (Han), Cuesta, M.A. (Miguel), Blaisse, R.J.B., Busch, O.R.C. (Olivier), Ten Kate, F.J.W. (Fiebo J.W.), Creemers, G.J.M. (Geert-Jan), Punt, C.J.A. (Cornelis), Plukker, J.T. (John), Verheul, H.M.W. (Henk), Spillenaar Bilgen, E.J. (Ernst Jan), Dekken, H. (Herman) van, Sangen, M.J.C. (Maurice) van der, Rozema, T. (Tom), Biermann, K. (Katharina), Beukema, J.C. (Jannet), Piet, A.H.M. (A. H M), Rij, C.M. (Caroline) van, Reinders, J.G.P. (Jurrien), Tilanus, H.W. (Hugo), Steyerberg, E.W. (Ewout), Gaast, A. (Ate) van der, Sprangers, M.A.G. (Mirjam), Jan Van Lanschot, J.B. (J. B.), Noordman, B.J. (Bo Jan), Verdam, M.G.E. (Mathilde G.E.), Lagarde, S.M. (Sjoerd), Hulshof, M.C.C.M. (Maarten), Van Hagen, P. (Pieter), van Berge Henegouwen, M.I., Wijnhoven, B.P.L. (Bas), Laarhoven, H.W.M. (Hanneke) van, Nieuwenhuijzen, G.A.P. (Gerard), Hospers, G.A.P. (Geke), Bonenkamp, J.J. (Han), Cuesta, M.A. (Miguel), Blaisse, R.J.B., Busch, O.R.C. (Olivier), Ten Kate, F.J.W. (Fiebo J.W.), Creemers, G.J.M. (Geert-Jan), Punt, C.J.A. (Cornelis), Plukker, J.T. (John), Verheul, H.M.W. (Henk), Spillenaar Bilgen, E.J. (Ernst Jan), Dekken, H. (Herman) van, Sangen, M.J.C. (Maurice) van der, Rozema, T. (Tom), Biermann, K. (Katharina), Beukema, J.C. (Jannet), Piet, A.H.M. (A. H M), Rij, C.M. (Caroline) van, Reinders, J.G.P. (Jurrien), Tilanus, H.W. (Hugo), Steyerberg, E.W. (Ewout), Gaast, A. (Ate) van der, Sprangers, M.A.G. (Mirjam), and Jan Van Lanschot, J.B. (J. B.)

Abstract

Purpose To compare pre-agreed health-related quality of life (HRQOL) domains in patients with esophageal or junctional cancer who received neoadjuvant chemoradiotherapy (nCRT) followed by surgery or surgery alone. Secondary aims were to examine the effect of nCRT on HRQOL before surgery and the effect of surgery on HRQOL. Patients and Methods Patients were randomly assigned to nCRT (carboplatin plus paclitaxel with concurrent 41.4-Gy radiotherapy) followed by surgery or surgery alone. HRQOL was measured using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Core 30 (QLQ-C30) and –Oesophageal Cancer Module (QLQ-OES24) questionnaires pretreatment and at 3, 6, 9, and 12 months postoperatively. The nCRT group also received preoperative questionnaires. Physical functioning (PF; QLQ-C30) and eating problems (EA; QLQ-OES24) were chosen as predefined primary end points. Predefined secondary end points were global QOL (GQOL; QLQ-C30), fatigue (FA; QLQ-C30), and emotional problems (EM; QLQ-OES24). Results A total of 363 patients were analyzed. No statistically significant differences in postoperative HRQOL were found between treatment groups. In the nCRT group, PF, EA, GQOL, FA, and EM scores deteriorated 1 week after nCRT (Cohen’s d: 20.93, P, .001; 0.47, P, .001; 20.84, P, .001; 1.45, P, .001; and 0.32, P = .001, respectively). In both treatment groups, all end points declined 3 months postoperatively compared with baseline (Cohen’s d: 21.00, 0.33, 20.47, 20.34, and 0.33, respectively; all P, .001), followed by a continuous gradual improvement. EA, GQOL, and EM were restored to baseline levels during follow-up, whereas PF and FA remained impaired 1 year postoperatively (Cohen’s d: 0.52 and 20.53, respectively; both P, .001). Conclusion Although HRQOL declined during nCRT, no effect of nCRT was apparent on postoperative HRQOL compared with surgery alone. In addition to the improvement in survival, these findings support the view th

Published
2018
Full Text
View/download PDF

16. Diagnostics in Celiac Disease

Author

Nieuwenhuis, E.E.S., ten Kate, F.J.W., Houwen, RHJ, Mubarak, A., Nieuwenhuis, E.E.S., ten Kate, F.J.W., Houwen, RHJ, and Mubarak, A.

Published
2014

17. Diagnostics in Celiac Disease

Author

Child Health, Infection & Immunity, Cancer, Regenerative Medicine and Stem Cells, MDL, Nieuwenhuis, E.E.S., ten Kate, F.J.W., Houwen, Roderick, Mubarak, A., Child Health, Infection & Immunity, Cancer, Regenerative Medicine and Stem Cells, MDL, Nieuwenhuis, E.E.S., ten Kate, F.J.W., Houwen, Roderick, and Mubarak, A.

Published
2014

23. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

Author

van Hagen, P., primary, Hulshof, M.C.C.M., additional, van Lanschot, J.J.B., additional, Steyerberg, E.W., additional, Henegouwen, M.I. van Berge, additional, Wijnhoven, B.P.L., additional, Richel, D.J., additional, Nieuwenhuijzen, G.A.P., additional, Hospers, G.A.P., additional, Bonenkamp, J.J., additional, Cuesta, M.A., additional, Blaisse, R.J.B., additional, Busch, O.R.C., additional, ten Kate, F.J.W., additional, Creemers, G.-J., additional, Punt, C.J.A., additional, Plukker, J.T.M., additional, Verheul, H.M.W., additional, Bilgen, E.J. Spillenaar, additional, van Dekken, H., additional, van der Sangen, M.J.C., additional, Rozema, T., additional, Biermann, K., additional, Beukema, J.C., additional, Piet, A.H.M., additional, van Rij, C.M., additional, Reinders, J.G., additional, Tilanus, H.W., additional, and van der Gaast, A., additional

Published
2012
Full Text
View/download PDF

24. Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancer

Author

van Heijl, M., primary, Phoa, S.S.K.S., additional, van Berge Henegouwen, M.I., additional, Omloo, J.M.T., additional, Mearadji, B.M., additional, Sloof, G.W., additional, Bossuyt, P.M.M., additional, Hulshof, M.C.C.M., additional, Richel, D.J., additional, Bergman, J.J.G.H.M., additional, ten Kate, F.J.W., additional, Stoker, J., additional, and van Lanschot, J.J.B., additional

Published
2011
Full Text
View/download PDF

27. Benelux multicentre trial of alpha interferon treatment for chronic hepatitis C: standard v high dose treatment monitored by biochemical and virological markers (interim analysis)

Author

Brouwer, J.T., Kleter, G.E.M., Hop, W.C.J., Quint, W.G.V., Heijtink, R.A., Schalm, S.W., Nevens, F., Fevery, J., Elewaut, A., Versieck, J., Adler, M., Bourgeois, N., Brenard, R., Geubel, A.P., Chamuleau, R.A.F.M., Reesinck, H.W., Jansen, P.L.M., Bronkhorst, C., ten Kate, F.J.W., Pirotte, J., Hautekeete, M.L., Michielsen, Peter, Henrion, J., den Ouden, J.W., de Galoscy, C., de Vries, R.A., van Munster, J.P., Wismans, P.J., van Ditzhuysen, Th.J.M., and Benelux Multicentre Trial Study Group

Published
1993

28. Reply

Author

Snoeren, N., primary, Jansen, M.C., additional, ten Kate, F.J.W., additional, and van Gulik, T.M., additional

Published
2009
Full Text
View/download PDF

30. P66 Proteomic patterns in blood of ovarian cancer patients

Author

Wegdam, W., primary, Moerland, P.D., additional, Buist, M.R., additional, Ver Loren van Themaat, E., additional, Blijlevens, B., additional, ten Kate, F.J.W., additional, Hoefsloot, H.J.C., additional, Richel, D.G., additional, de Koster, C.G., additional, and Aerts, J.M.F.G., additional

Published
2007
Full Text
View/download PDF

45. Inhibin immunoreactivity in gonadal and non-gonadal tumors

Author

De Jong, F.H., primary, Grootenhuis, A.J., additional, Steenbergen, J., additional, van Sluijs, F.J., additional, Foekens, J.A., additional, ten Kate, F.J.W., additional, Oosterhuis, J.W., additional, Lamberts, S.W.J., additional, and Klijn, J.G.M., additional

Published
1990
Full Text
View/download PDF

48. Routine morphometrical analysis can improve reproducibility of dysplasia grade in Barrett's oesophagus surveillance biopsies.

Author

Baak, J.P.A., ten Kate, F.J.W., Offerhaus, G.J.A., van Lanschot, J.J., and Meijer, G.A.

Subjects
ESOPHAGEAL cancer, BIOPSY, DYSPLASIA
Abstract

Background: The grade of dysplasia found in Barrett's oesophagus surveillance biopsies is a major factor to determine follow up and treatment. However, it has been reported that the reproducibility of the grading system is not optimal. Aims: To compare routine and expert dysplasia grades in Barrett's oesophagus surveillance biopsies. To evaluate prospectively morphometrical grading support and to assess the pitfalls in its daily application. Methods: Consecutive biopsies (n = 143) were graded routinely by experienced general surgical pathologists as no dysplasia (ND), indefinite for dysplasia, low grade dysplasia (LGD), and high grade dysplasia (HGD). Two expert gastrointestinal pathologists blindly reviewed all sections. The stratification index of nuclei, mean nuclear area, and Ki67 area% were assessed routinely according to a strict protocol. With these features, the previously described morphometrical grade was calculated for each case. The grades provided by the experts, surgical pathologists, and morphometry were compared. Results: The general pathologists graded many more cases as dysplastic than did the experts. Complete agreement between the experts' grades and the original grades was 50 of 143 (35%). Sixty four of the 71 original LGDs and 11 of the 23 original HGDs were downgraded by the experts, whereas one LGD was upgraded. In 93 of the 143 biopsies, at review pitfalls or special characteristics of a technical nature (tangential cutting, severe inflammation, ulcer or the squamocylindrical junction very close by, among others) were seen in the part of the biopsy marked as diagnostic. These probably contributed in part to the original overdiagnoses and could have been prevented or corrected. The morphometrical grading model has not been developed to compensate for this; application of the current morphometrical grading method is not allowed and may result in erroneous (usually too high) morphometrical grades. In spite of this, all HGDs according to... [ABSTRACT FROM AUTHOR]

Published
2002
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results